Star Behavioral Health in Roanoke, Virginia logo

People with treatment-resistant depression and/or acute suicidal ideation can find relief from their debilitating symptoms at Star Behavioral Health. The health center provides Spravato ketamine for patients that have not found recovery through traditional forms of treatment. Spravato is the intranasal form of ketamine administration, also known as Esketamine.

Star Behavioral Health is led by Dr. Pamela Ruppel, a psychiatric nurse practitioner. With over two decades of experience, Dr. Ruppel has both the expertise and the compassion to help patients overcome their diseases. She and the team at the mental health center approach each patient as an individual for a truly unique and tailored patient experience. By using breakthrough ketamine therapy along with other forms of traditional mental therapy, Dr. Ruppel has helped many people regain control of their health.

Offered Treatments

  • Spravato (Esketamine Nasal Spray)

Treated Conditions

  • Treatment-Resistant Depression
    • Star Behavioral Health defines this as failure to have an adequate response to two separate SSRIs and one other antidepressant.
  • Acute Suicidal Ideation

Important Info

  • Spravato referrals are accepted at this time, and the process for authorization usually takes about 2-3 weeks at a minimum from the referral date to completely process it with insurance and scheduling. It may be faster depending on insurance response time.
  • Star Behavioral Health’s office is on the first floor, handicap accessible, and parking is safe, next to the building, and free.
  • The clinic has a secure patient portal that can be used for confidential questions, advice, and scheduling.

Contact Information

  • Address: 4806 Pleasant Hill Drive, Suite 102, Roanoke, VA 24018
  • Phone: 540-512-9754
  • Email: pamela@starhealthroanoke.com

What to Know About Esketamine

Spravato, also known as Esketamine, is taken as a nasal spray and typically prescribed in conjunction with a conventional oral antidepressant, as it may enhance the effect of those drugs.

In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. A year later, the agency added patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.

Discover more Virginia Ketamine Clinics:

Location

Add Review

Leave a Reply

Your email address will not be published. Required fields are marked *

Service
Value for Money
Location
Cleanliness

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Now Closed

Opening Hours

  • Monday 9:00 AM - 5:00 PM
  • Tuesday 9:00 AM - 5:00 PM
  • Wednesday 9:00 AM - 5:00 PM
  • Thursday 9:00 AM - 5:00 PM
  • Friday 9:00 AM - 5:00 PM
  • SaturdayClosed
  • SundayClosed

Search

type and hit enter